Finance

Lists
SOFW:TLV
Sofwave Medical Ltd
ILA 3,605.00
-1.04%
(-38.00) 1D
Aug 11, 5:26:00 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for SOFW...
Open
ILA 3,554.00
High
ILA 3,642.00
Low
ILA 3,550.00
Mkt. cap
1.31B
Avg. vol.
85.83K
Volume
29.18K
P/E ratio
61.47
52-wk high
ILA 4,869.00
52-wk low
ILA 2,417.00
EPS
ILA 0.59
Shares outstanding
36.35M
No. of employees
151
Open
ILA 3,554.00
High
ILA 3,642.00
Low
ILA 3,550.00
Mkt. cap
1.31B
Avg. vol.
85.83K
Volume
29.18K
P/E ratio
61.47
52-wk high
ILA 4,869.00
52-wk low
ILA 2,417.00
EPS
ILA 0.59
Shares outstanding
36.35M
No. of employees
151
Profile
Sofwave Medical is an Israeli aesthetic medicine company with headquarters in California, United States. It is publicly traded, listed on the Tel Aviv Stock Exchange. Sofwave develops an ultrasound system for non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles and for short term improvement in the appearance of cellulite. Wikipedia
About Sofwave Medical Ltd
CEOLouis Scafuri
Employees151
Founded2015
Headquarters-
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
21.07M
28.90M
24.41M
29.96M
Cost of goods sold
5.54M
7.05M
6.11M
7.05M
Cost of revenue
5.54M
7.05M
6.11M
7.05M
Research and development expenses
3.16M
3.74M
3.77M
3.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.89M
13.96M
12.90M
16.12M
Operating expense
14.04M
17.70M
16.67M
20.06M
Total operating expenses
19.59M
24.74M
22.78M
27.11M
Operating income
1.49M
4.16M
1.63M
2.85M
Other non operating income
-
-1.79M
-
-
EBT including unusual items
1.29M
3.96M
1.46M
2.49M
EBT excluding unusual items
1.29M
3.96M
1.46M
2.49M
Income tax expense
310.00K
-136.00K
197.00K
-18.00K
Effective tax rate
23.99%
-3.43%
13.51%
-0.72%
Other operating expenses
-
-
-
-
Net income
982.00K
4.10M
1.26M
2.51M
Net profit margin
4.66%
14.19%
5.17%
8.38%
Earnings per share
-
-
-
-
Interest and investment income
190.00K
1.54M
316.00K
242.00K
Interest expense
-386.00K
-
-485.00K
-603.00K
Net interest expenses
-196.00K
1.54M
-169.00K
-361.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
2.00M
4.42M
2.14M
3.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps